CSIMarket Company Name, Ticker, Customers, else..
 
Flora Growth Corp   (NASDAQ: FLGC)
Other Ticker:  
 
 
Price: $0.5501 $0.03 5.788%
Day's High: $0.5768 Week Perf: 18.81 %
Day's Low: $ 0.52 30 Day Perf: -16.31 %
Volume (M): 102 52 Wk High: $ 2.11
Volume (M$): $ 56 52 Wk Avg: $1.10
Open: $0.52 52 Wk Low: $0.42



 Market Capitalization (Millions $) 7
 Shares Outstanding (Millions) 12
 Employees 76
 Revenues (TTM) (Millions $) 41
 Net Income (TTM) (Millions $) -69
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Flora Growth Corp
Flora Growth Corp is a Canadian-based cannabis company that operates in the global market. The company focuses on the cultivation, processing, and distribution of premium-grade cannabis and cannabis-derived products. Flora Growth aims to become a dominant player in the international cannabis industry by leveraging its vertically integrated supply chain, strategic partnerships, and brand development. The company emphasizes sustainable and ecologically-friendly practices in its operations, and it is committed to providing high-quality products to meet the evolving demands of the global cannabis market.


   Company Address: 3230 W. Commercial Boulevard Fort Lauderdale 33309 FL
   Company Phone Number: 842-4989   Stock Exchange / Ticker: NASDAQ FLGC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSPK        13.2% 
CVSI   -9.67%    
ETST        44.14% 
IGC        6.64% 
LEXX        7.77% 
LIFD        7.77% 
• View Complete Report
   



Unity Biotechnology Inc

The Major Pharmaceutical Preparations company added some great scenario for the investors, presenting a relevant growth in January to March 31 2025 with operating shortfall of $-6.891 million

The investors have not assumed any adjustments at the revenue throughout the the January to March 31 2025 reporting cycle at the UBX. But, they pay very near attention to the company's operating shortfall which came in at $-6.891 million, in the same period.

Bioadaptives Inc

Observing the fourth quarter of 2024 results, the company's saw top-line has dropped by -88.085 %

For the fiscal fourth quarter of 2024 company reached break-even of $0.00 per share compare to $0.00 a year before and from $0.00 per share from the previous reporting period. The revenue fell sharply to $0.00 million from $0.01 million in the same reporting period a year before and sequentially from $0.00 million.

Transcode Therapeutics Inc

The Major Pharmaceutical Preparations company published operating loss of $-5.092387 million, in the October to December 31 2024 time-frame

While the October to December 31 2024 reporting cycle resumes, many companies have reported the respective earnings. In the thick of it, have been various entities in the Major Pharmaceutical Preparations sector. As well as, now, Transcode Therapeutics Inc reported operating loss of $-5.092387 million, for the October to December 31 2024 time-frame.

Eyenovia Inc

The Deficit has widen more at the Major Pharmaceutical Preparations company amid the October to December 31 2024 financial time-frame

Eyenovia Inc announced very solid Revenue rise year on year to $0.03 million in the October to December 31 2024 span, but increased a deficit per share at $-59.26.

Vaccinex Inc

The company announced Revenue of $0.199 million, in the fiscal interval ending December 31 2024

Vaccinex Inc has seen $0.199 million, in Revenue in the fourth quarter of 2024.







Flora Growth's Segments
Commercial & Wholesale    62.9 % of total Revenue
House of Brands    44.48 % of total Revenue
Corp & Eliminations    100 % of total Revenue
United States    36.15 % of total Revenue
Germany    62.91 % of total Revenue
United Kingdom    0.94 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com